Finasteride vs Trastuzumab

Finasteride vs Trastuzumab: Overview

This comparison examines the pharmacological differences between Finasteride and Trastuzumab.

Mechanism of Action

Finasteride: Competitive inhibitor of 5-alpha-reductase type II.

Trastuzumab: Anti-HER2 monoclonal antibody inhibiting receptor signaling.

Pharmacokinetics

Half-life: Finasteride — 5-6 hours; Trastuzumab — 28 days.

Chemical Properties

Molecular Formula: Finasteride — C23H36N2O2.

Molecular Weight: Finasteride — 372.5490 g/mol.

Type: Finasteride — Small molecule; Trastuzumab — Antibody.